Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

929
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
929
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

7.6K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.6K
Mitochondrial Membranes01:45

Mitochondrial Membranes

10.0K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
10.0K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

3.9K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.9K
Translation01:31

Translation

141.8K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
141.8K
Erythropoiesis01:14

Erythropoiesis

4.2K
Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variant classification for mucopolysaccharidosis type I; ACMG/AMP specification for IDUA from the ClinGen lysosomal diseases variant curation expert panel.

Molecular genetics and metabolism·2026
Same author

Clinical Outcomes and Correlation With Biochemical Control in Hydroxocobalamin-Treated Patients With Early-Onset Cobalamin C Disease.

JIMD reports·2026
Same author

Mixed Autoimmune Hemolytic Anemia With Refractory Cold Agglutinin Syndrome in a Child Successfully Treated With Serial Whole Blood Exchange Transfusions and Immunosuppression.

Journal of pediatric hematology/oncology·2026
Same author

Antenatal and Neonatal Management of Siblings With Carbonic Anhydrase VA Deficiency.

JIMD reports·2026
Same author

The History and Nosology of the Glycine Disorders: A Framework for Clinicians.

Journal of inherited metabolic disease·2026
Same author

Germline mutations in a G protein identify signaling cross-talk in T cells.

Science (New York, N.Y.)·2024

Related Experiment Video

Updated: Jun 24, 2025

Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer
10:17

Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer

Published on: September 24, 2021

2.6K

Hematologic Manifestations in Primary Mitochondrial Diseases.

Arthavan Selvanathan1, Juliana Teo2, Bindu Parayil Sankaran3

  • 1Genetic Metabolic Disorders Service, The Children's Hospital at Westmead, Westmead, NSW, Australia.

Journal of Pediatric Hematology/Oncology
|June 10, 2024
PubMed
Summary

Primary mitochondrial disorders (PMDs) can cause blood issues like anemia in 10-30% of patients. Understanding mitochondrial roles in hematopoiesis aids in diagnosing and managing these hematologic manifestations.

More Related Videos

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
09:44

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Published on: September 5, 2019

7.3K
Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
06:53

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry

Published on: November 23, 2011

36.8K

Related Experiment Videos

Last Updated: Jun 24, 2025

Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer
10:17

Assessment of Cellular Bioenergetics in Mouse Hematopoietic Stem and Primitive Progenitor Cells using the Extracellular Flux Analyzer

Published on: September 24, 2021

2.6K
Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
09:44

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Published on: September 5, 2019

7.3K
Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry
06:53

Visualization of Mitochondrial Respiratory Function using Cytochrome C Oxidase / Succinate Dehydrogenase COX/SDH Double-labeling Histochemistry

Published on: November 23, 2011

36.8K

Area of Science:

  • Biochemistry
  • Hematology
  • Genetics

Background:

  • Primary mitochondrial disorders (PMDs) present with diverse clinical features affecting multiple organ systems.
  • Hematologic abnormalities, including cytopenias and sideroblastic anemia, are observed in 10-30% of PMD patients.
  • These blood-related issues can be early signs or later complications of mitochondrial dysfunction.

Purpose of the Study:

  • To elucidate the pathophysiology of hematologic effects stemming from mitochondrial dysfunction.
  • To detail the diagnostic and management strategies for PMDs with a focus on hematologic manifestations.
  • To serve as a reference for clinicians evaluating hematologic abnormalities in the context of mitochondrial disease.

Main Methods:

  • Review of the literature on mitochondrial pathophysiology and hematopoiesis.
  • Discussion of the established roles of mitochondria in cellular energy production, heme synthesis, and iron-sulfur cluster generation.
  • Synthesis of information on the diagnosis and management of PMDs and their hematologic complications.

Main Results:

  • Mitochondria are crucial for hematopoiesis through energy provision, heme synthesis, and iron-sulfur cluster formation.
  • Specific hematologic conditions are frequently associated with PMDs.
  • Timely surveillance enables prompt diagnosis and effective treatment of these manifestations.

Conclusions:

  • Mitochondrial dysfunction significantly impacts hematopoiesis, leading to various blood disorders.
  • Recognizing the link between mitochondrial disease and hematologic abnormalities is critical for patient care.
  • This review provides a framework for understanding and addressing hematologic issues in PMD patients.